Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies

Journal of Virological Methods

Volumn 135, Issue 2, 2006, Pages 143-150

  Saeed, Mohammad F ^a   Kolokoltsov, Andrey A ^a   Davey, Robert A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Antivirals; Entry; Fusion; HIV; Rabies; Virus

Indexed keywords

HYBRID PROTEIN; LUCIFERASE; NEF PROTEIN; VIRUS PROTEIN;

ARTICLE; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INFRARED RADIATION; MEASUREMENT; PRIORITY JOURNAL; RABIES; SCREENING; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; VALIDATION PROCESS; VIRUS INFECTION;

CELLS, CULTURED; ENDOSOMES; HIV; HIV FUSION INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; RABIES VIRUS; RECEPTORS, VIRUS;

EID: 33745142510     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.02.011     Document Type: Article

References (32)

1. Alexander M., Bor Y.C., Ravichandran K.S., Hammarskjold M.L., and Rekosh D. Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity. J. Virol. 78 (2004) 1685-1696
2. Brault A.C., Powers A.M., Medina G., Wang E., Kang W., Salas R.A., De Siger J., and Weaver S.C. Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic. J. Virol. 75 (2001) 5823-5832
3. Cavrois M., De Noronha C., and Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20 (2002) 1151-1154
4. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 (1998) 681-684
5. Chazal N., and Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67 (2003) 226-237 (table of contents)
6. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7 (1978) 2745-2752
7. Chu J.J., and Ng M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J. Biol. Chem. 279 (2004) 54533-54541
8. Craig F.F., Simmonds A.C., Watmore D., McCapra F., and White M.R. Membrane-permeable luciferin esters for assay of firefly luciferase in live intact cells. Biochem. J. 276 Pt 3 (1991) 637-641
9. Danieli T., Pelletier S.L., Henis Y.I., and White J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133 (1996) 559-569
10. Davey R.A., Zuo Y., and Cunningham J.M. Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J. Virol. 73 (1999) 3758-3763
11. Dimitrov D.S. Virus entry: molecular mechanisms and biomedical applications. Nat. Rev. Microbiol. 2 (2004) 109-122
12. Empig C.J., and Goldsmith M.A. Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76 (2002) 5266-5270
13. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
14. Fredericksen B.L., Wei B.L., Yao J., Luo T., and Garcia J.V. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 76 (2002) 11440-11446
15. Kolokoltsov A.A., and Davey R.A. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J. Virol. 78 (2004) 5124-5132
16. Kolokoltsov A.A., Weaver S.C., and Davey R.A. Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J. Virol. 79 (2005) 756-763
17. Lakadamyali M., Rust M.J., Babcock H.P., and Zhuang X. Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9280-9285
18. Lu H., Zhao Q., Xu Z., and Jiang S. Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors. J. Virol. Meth. 107 (2003) 155-161
19. Meier O., and Greber U.F. Adenovirus endocytosis. J. Gene Med. 5 (2003) 451-462
20. Mothes W., Boerger A.L., Narayan S., Cunningham J.M., and Young J.A. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103 (2000) 679-689
21. Nemerow G.R. Cell receptors involved in adenovirus entry. Virology 274 (2000) 1-4
22. O'Hara B.M., and Olson W.C. HIV entry inhibitors in clinical development. Curr. Opin. Pharmacol. 2 (2002) 523-528
23. Paternostre M.T., Lowy R.J., and Blumenthal R. pH-dependent fusion of reconstituted vesicular stomatitis virus envelopes with Vero cells. Measurement by dequenching of fluorescence. FEBS Lett. 243 (1989) 251-258
24. Pelkmans L., Puntener D., and Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296 (2002) 535-539
25. Platt E.J., Durnin J.P., and Kabat D. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J. Virol. 79 (2005) 4347-4356
26. Pollack P., and Groothuis J.R. Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV. J. Infect. Chemother. 8 (2002) 201-206
27. Roche S., and Gaudin Y. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion. J. Virol. 78 (2004) 8746-8752
28. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., and Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
29. Sanders D.A. No false start for novel pseudotyped vectors. Curr. Opin. Biotechnol. 13 (2002) 437-442
30. Sandrin V., Boson B., Salmon P., Gay W., Negre D., Le Grand R., Trono D., and Cosset F.L. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100 (2002) 823-832
31. Sinangil F., Loyter A., and Volsky D.J. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett. 239 (1988) 88-92
32. Welker R., Kottler H., Kalbitzer H.R., and Krausslich H.G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219 (1996) 228-236